HIT Consultant January 26, 2024
What You Should Know:
– Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from prominent players like KdT Ventures, Satori Neuro, and Dolby Family Ventures, alongside existing supporters Divergent Capital and PsyMed Ventures.
– Motif Neurotech’s innovative approach represents a potential paradigm shift in mental health treatment. By leveraging the power of bioelectronics, they aim to offer a safer, more targeted, and potentially more effective option for patients suffering from TRD.
Hope for Millions Struggling with TRD
TRD, a form of major depressive disorder unresponsive to traditional medications, affects millions worldwide. It can be a debilitating condition, leaving patients feeling...
Today's Sponsors
Today's Sponsor